托代谢和肠道微生物群:对炎症性肠道疾病的影响
Xue Hua1, Yongchao Chen1, Sujuan Ding1
1College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
Microbiological research
|July 25, 2025
概括
托芬代谢和肠道微生物显著影响炎症性肠病 (IBD). 了解这些相互作用为IBD提供了新的治疗策略,准托芬通路以恢复肠道健康和免疫平衡.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 托芬代谢对肠道健康和免疫功能至关重要.
- 肠道微生物群显著影响托代谢.
- 肠道微生物群中的失生症可以扰乱托代谢,可能使IBD恶化.
研究的目的:
- 审查IBD中的肠道微生物群和托代谢之间的相互作用.
- 阐明托代谢及其产品在IBD病变发生过程中的机制.
- 探索基于调节托代谢的IBD治疗策略.
主要方法:
- 关于托代谢,肠道微生物群和IBD的研究的文献综述.
- 分析基碳化合物受体 (AhR) 信号传递,免疫细胞和因子的作用.
- 检查克罗恩病 (CD) 和性结肠炎 (UC) 中特有的托芬代谢物功能的检查.
主要成果:
- 甲的代谢物,如5-HT,KYN和类同类物,在肠道健康和免疫力中起着关键作用.
- 肠道微生物群的组成和功能直接影响托的代谢平衡.
- 扰乱托代谢与IBD恶化有关.
结论:
- 调节托代谢为IBD提供了一个有前途的治疗途径.
- 托芬代谢物的功能在CD和UC之间以及疾病阶段之间有所不同.
- 对托代谢和肠道微生物群相互作用的进一步研究可以促进IBD临床管理.
相关概念视频
Irritable Bowel Syndrome I: Introduction
390
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
390
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
422
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
422
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
235
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
235
Inflammatory Bowel Disease II: Crohn's Disease
387
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
387
Inflammatory Bowel Disease I: Ulcerative Colitis
326
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
326


